AppX vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Indian creator economy platform enabling branded mobile app launching for digital product sales; $2M revenue backed by YC helping creators sell courses and e-books directly to audiences.
About
AppX is a New Delhi-based creator economy platform that enables social media creators to build branded mobile apps and websites to monetize their audience directly — offering tools to sell e-books, online courses, digital downloads, NFTs, and e-commerce products through a creator-owned branded app rather than relying entirely on social platform algorithms and monetization programs. Founded in 2020 and a Y Combinator graduate, AppX raised $1.3 million in seed funding and reached $2 million in revenue by 2024 with 67 employees, targeting the growing Indian and global creator population seeking direct monetization beyond Instagram, YouTube, and TikTok.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.